Delisting riskPopularity #3,932
ONCY · NASDAQ · Biotechnology

Oncolytics Biotech (ONCY)

Develops pelareorep, a double-stranded RNA immunotherapy for gastrointestinal tumors.

$0.6714
vs last close−0.04 (−5.87%)